A Phase I, Dose Escalation, Open-label, Multicenter Study of EA5 Injection in Adults With APS and Recurrent Thrombosis

NCT07632976 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Antiphospholipid Syndrome (APS)
Thrombosis

Interventions

BIOLOGICAL: EA5
BIOLOGICAL: EA5

Sponsor

Shanghai Lanyi Therapeutics Co., Ltd.